hyaluronic acid nanogel vaccine (Asahi Kasei)

N/A

Report date: 2025/06/11 10:16:09

Base Information

Drug Namehyaluronic acid nanogel vaccine (Asahi Kasei)
Drug Alias NameHANG-VaxHANG-V (Asahi Kasei)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionCluster of differentiation 8 modulators
TargetsCluster of differentiation 8
Therapy Area/IndicationsSolid tumoursMelanomaSarcoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAsahi Kasei Corp
China Registration ClassN/A

Develop Information

Active CompaniesAsahi Kasei Corp
Inactive CompaniesN/A
Active IndicationsSolid tumoursMelanomaSarcoma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A